Kazandjian, D., Suzman, D. L., Blumenthal, G., Mushti, S., He, K., Libeg, M., . . . Pazdur, R. (2016). FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy. Oncologist.

Kazandjian, Dickran, Daniel L. Suzman, Gideon Blumenthal, Sirisha Mushti, Kun He, Meredith Libeg, Patricia Keegan, a Richard Pazdur. "FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy." Oncologist 2016.

Kazandjian, Dickran, et al. "FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy." Oncologist 2016.